Transcatheter Aortic Valve Implantation (TAVI)

Medic in white coat holding digital heart

Home » National Cardiac Audit Programme » Transcatheter Aortic Valve Implantation (TAVI)

The UK Transcather Aortic Valve Implantation (UK TAVI) Registry icon

The Structural Heart Intervention Registries are within the National Cardiac Audit Programme (NCAP). There are four structural heart intervention registries including Transcatheter Aortic Valve Implantation (TAVI).

The UK TAVI program was established to capture and report outcomes on TAVI procedures performed in the UK. TAVI (transcatheter aortic valve implantation) provides a less invasive alternative to cardiac surgery and avoids the requirement for cardiopulmonary bypass.

The UK TAVI registry was created to define the characteristics and clinical outcomes of the patient population treated with TAVI, regardless of technology or access route, in every centre performing TAVI in the UK.

The project aims to capture detailed information on how TAVI is used to treat patients with severe aortic stenosis and significant comorbidities; improving the care of patients and benchmarking TAVI units to learn best practice.

The practice of collecting comprehensive clinical and outcome data by registry is a significant development in the introduction of new treatment technologies within the NHS. This process may help to shape commissioning by evaluation and encourage the safe introduction of new technologies into the NHS.

The registry is managed by NICOR with clinical direction and strategy provided by the British Cardiovascular Interventional Society (BCIS), the Society for Cardiothoracic Surgeons (SCTS).

The 2024 TAVI report and TAVI Overview of QI metrics covers the 12 months from 01 April 2022 to 31 March 2023.